CD7 Antikörper (FITC)

Produktnummer ABIN2704321

Produktdetails anti-CD7 Antikörper (FITC)

Target: CD7

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser CD7 Antikörper ist konjugiert mit FITC

Applikation: Flow Cytometry (FACS)

Produktmerkmale: The clone 4H9 recognizes the 40 kDa CD7 antigen abundantly expressed on the human T and NK lymphocytes. The CD7 antigen is expressed throughout T lymphocyte differentiation and is present on 85 % to 90 % of peripheral blood T cells. In normal individuals, the CD7 antibody reacts with all CD8+ T cells, approximately 90 % of CD4+ T cells, and most NK cells. CD7 is weakly reactive with monocytes and does not react with granulocytes or B lymphocytes. It is also expressed on 50 % of thymocytes. In leukemias, the CD7 antigen is present on most T lymphoid lineages.

Aufreinigung: Purified

Reinheit: >95 %

Güteklasse: GMP Grade

Immunogen: T-acute lymphoblastic leukemia cells

Klon: 4H9

Isotyp: IgG2a kappa

Anwendungsinformationen

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 200 μg/mL

Buffer: PBS pH 7.2, 0.2 % (w/v) BSA, 0.09 % (w/v) sodium azide

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C

Details zu CD7

Target: CD7

Andere Bezeichnung: CD7 (CD7 Produkte)

Synonyme: GP40 antikoerper, LEU-9 antikoerper, TP41 antikoerper, Tp40 antikoerper, CD7 molecule antikoerper, CD7 antigen antikoerper, Cd7 molecule antikoerper, CD7 antikoerper, Cd7 antikoerper

Hintergrund: The clone 4H9 recognizes the 40 kDa CD7 antigen abundantly expressed on the human T and NK lymphocytes. The CD7 antigen is expressed throughout T lymphocyte differentiation and is present on 85 % to 90 % of peripheral blood T cells. In normal individuals, the CD7 antibody reacts with all CD8+ T cells, approximately 90 % of CD4+ T cells, and most NK cells. CD7 is weakly reactive with monocytes and does not react with granulocytes or B lymphocytes. It is also expressed on 50 % of thymocytes. In leukemias, the CD7 antigen is present on most T lymphoid lineages.

NCBI Accession: NM_006137

UniProt: P09564

Pathways: Cell-Cell Junction Organization